The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis
Open accessAbstract
To determine whether multiple sclerosis (MS) risk increases following primary infection with the Epstein‐Barr virus (EBV), we conducted a nested case‐control study including 305 individuals who developed MS and 610 matched controls selected among the >8 million active‐duty military personnel whose serum has been stored in the Department of Defense Serum Repository. Time of EBV infection was determined by measuring antibody titers in serial serum samples collected before MS onset among cases, and on matched dates among controls. Ten (3.3%) cases and 32 (5.2%) controls were initially EBV negative. All of the 10 EBV‐negative cases became EBV positive before MS onset; in contrast, only 35.7% (n = 10) of the 28 controls with follow‐up samples seroconverted (exact p value = 0.0008). We conclude that MS risk is extremely low among individuals not infected with EBV, but it increases sharply in the same individuals following EBV infection. ANN NEUROL 2010;67:824–830
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
Self-citationEnvironmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Self-citationViral Infections of Humans. Epidemiology and Control.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-2-273_2 · Cited by 749
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
Self-citationEpstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001) · JAMA · doi:10.1001/jama.286.24.3083 · Cited by 549
Self-citationEpstein-barr virus specific diagnostic tests in infectous mononucleosis
Henle, W., Henle, G., & Horwitz, C. A. (1974) · Human Pathology · doi:10.1016/s0046-8177(74)80006-7 · Cited by 528
Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis
Thacker, E. L., Mirzaei, F., & Ascherio, A. (2006) · Annals of Neurology · doi:10.1002/ana.20820 · Cited by 517
Self-citationLevin, L. I. (2005) · JAMA · doi:10.1001/jama.293.20.2496 · Cited by 448
Self-citationEpstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 310
Rubertone, M. V., & Brundage, J. F. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.12.1900 · Cited by 304
An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., Dillner, J., & Forsgren, L. (2004) · Neurology · doi:10.1212/01.wnl.0000130496.51156.d7 · Cited by 301
Epstein-Barr Virus in Pediatric Multiple Sclerosis
Alotaibi, S. (2004) · JAMA · doi:10.1001/jama.291.15.1875 · Cited by 280
DeLorenze, G. N., Munger, K. L., Lennette, E. T., Orentreich, N., Vogelman, J. H., & Ascherio, A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.noc50328 · Cited by 257
Self-citationHigh seroprevalence of Epstein–Barr virus in children with multiple sclerosis
Pohl, D., Krone, B., Rostasy, K., Kahler, E., Brunner, E., Lehnert, M., Wagner, H. J., Gärtner, J., & Hanefeld, F. (2006) · Neurology · doi:10.1212/01.wnl.0000247665.94088.8d · Cited by 226
Multiple Sclerosis After Infectious Mononucleosis
Nielsen, T. R., Rostgaard, K., Nielsen, N. M., Koch-Henriksen, N., Haahr, S., Sørensen, P. S., & Hjalgrim, H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.72 · Cited by 214
Crawford, D. H., Macsween, K. F., Higgins, C. D., Thomas, R., McAulay, K., Williams, H., Harrison, N., Reid, S., Conacher, M., Douglas, J., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/505400 · Cited by 209
Epstein-Barr Virus and Multiple Sclerosis
Ascherio, A., & Munch, M. (2000) · Epidemiology · doi:10.1097/00001648-200003000-00023 · Cited by 206
Self-citationLebrun‐Frénay, C., Bensa, C., Debouverie, M., Seze, J. D., Wiertlievski, S., Brochet, B., Clavelou, P., Brassat, D., Labauge, P. M., Roullet, E., et al. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108274 · Cited by 135
Lennette, E. T., Rymo, L., Yadav, M., Masucci, G. V., Merk, K., Tı́már, L., & Klein, G. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90299-u · Cited by 65
Cited by
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Self-citationInteractions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Hemmer, B., Kerschensteiner, M., & Korn, T. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70305-9 · Cited by 584
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
Metadata
- Authors
- Levin, L. I., Munger, K. L., O'Reilly, E. J., Falk, K. I., & Ascherio, A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2010-05-25
- Volume
- 67
- Issue
- 6
- Pages
- 824-830
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2112982280
- Cited by
- 404
- References
- 19
- FWCI
- 18.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.